Shareholders elect 10 directors, approve 2024 Omnibus Incentive Plan at AGM

NovoCure Ltd

Approximately 85.9M shares (79.8% of eligible) voted at June 5 AGM; all 10 director nominees elected.
Auditor ratification passed: 80.1M for, 5.7M against, 0.09M abstain.
Non-binding advisory vote on executive compensation approved: 69.6M for, 1.2M against.
2024 Omnibus Incentive Plan approved: 60.1M for (73.7% of votes cast), 10.8M against.
Say-on-pay frequency set at one year: 70.5M for one year vs 0.4M for three years.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.